Aura Biosciences (AURA) Non Operating Income (2021 - 2026)

Aura Biosciences has reported Non Operating Income for 6 years, with the latest figure at $2000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 99.87% year-over-year to $2000.0; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (up 37.41% YoY), and the FY2025 full-year result was $6.7 million, up 5690.0% from the prior year.
• Non Operating Income for Q1 2026 stood at $2000.0, down from $1.7 million in the prior quarter.
• The five-year high for Non Operating Income was $2.8 million in Q4 2023, with the low at -$37000.0 in Q4 2024.
• Historically, Non Operating Income has averaged $929588.2 across 5 years, with a median of $348000.0 in 2022.
• Annual changes were most pronounced in 2022 — Non Operating Income jumped 52800.0% — and 2023, when it sank 109.2%.
• Aura Biosciences' Non Operating Income stood at $1.1 million in 2022, then jumped by 164.61% to $2.8 million in 2023, then sank by 101.33% to -$37000.0 in 2024, then soared by 4675.68% to $1.7 million in 2025, then slumped by 99.88% to $2000.0 in 2026.
• The last three Non Operating Income figures came in at $2000.0 (Q1 2026), $1.7 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.